C
Clovis Oncology Inc
XETRA:C6O
Clovis Oncology Inc
XETRA:C6O
Price:
8.7
EUR
-10.66%
Market Cap:
€3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Clovis Oncology Inc
XETRA:C6O
|
US |
|
Little Green Pharma Ltd
ASX:LGP
|
AU |
|
P
|
Pre-Built PCL
SET:PREB
|
TH |
|
E
|
eSang Networks Co Ltd
KOSDAQ:080010
|
KR |
|
Ramelius Resources Ltd
ASX:RMS
|
AU |
|
S
|
Spirit Blockchain Capital Inc
CNSX:SPIR
|
CA |
|
Jay Shree Tea and Industries Ltd
NSE:JAYSREETEA
|
IN |
|
I
|
IToxi Corp
KOSDAQ:052770
|
KR |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is C6O's stock price target?
Not Available
C6O doesn't have any price targets made by Wall Street professionals.
What is Clovis Oncology Inc's Revenue forecast?
Projected CAGR
-4%
-4%
The compound annual growth rate of Clovis Oncology Inc's revenue for the next 2 years is -4%.
